NO972963L - Flerfaset mykgelatin-doseringsform - Google Patents

Flerfaset mykgelatin-doseringsform

Info

Publication number
NO972963L
NO972963L NO972963A NO972963A NO972963L NO 972963 L NO972963 L NO 972963L NO 972963 A NO972963 A NO 972963A NO 972963 A NO972963 A NO 972963A NO 972963 L NO972963 L NO 972963L
Authority
NO
Norway
Prior art keywords
dosage form
soft gelatin
gelatin dosage
multiphase
multiphase soft
Prior art date
Application number
NO972963A
Other languages
English (en)
Norwegian (no)
Other versions
NO972963D0 (no
Inventor
Michael R Hoy
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of NO972963D0 publication Critical patent/NO972963D0/no
Publication of NO972963L publication Critical patent/NO972963L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO972963A 1996-06-28 1997-06-25 Flerfaset mykgelatin-doseringsform NO972963L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/671,979 US6024980A (en) 1996-06-28 1996-06-28 Multiphase soft gelatin dosage form

Publications (2)

Publication Number Publication Date
NO972963D0 NO972963D0 (no) 1997-06-25
NO972963L true NO972963L (no) 1997-12-29

Family

ID=24696660

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972963A NO972963L (no) 1996-06-28 1997-06-25 Flerfaset mykgelatin-doseringsform

Country Status (24)

Country Link
US (1) US6024980A (id)
EP (1) EP0815855B1 (id)
JP (1) JPH10182437A (id)
KR (1) KR980000438A (id)
CN (1) CN1172642A (id)
AR (1) AR007648A1 (id)
AT (1) ATE223707T1 (id)
AU (1) AU2620197A (id)
BR (1) BR9703771A (id)
CO (1) CO4900025A1 (id)
CZ (1) CZ205697A3 (id)
DE (1) DE69715319T2 (id)
DK (1) DK0815855T3 (id)
ES (1) ES2183089T3 (id)
HU (1) HUP9701113A2 (id)
ID (1) ID17794A (id)
IL (1) IL121145A0 (id)
NO (1) NO972963L (id)
NZ (1) NZ328182A (id)
PL (1) PL320815A1 (id)
PT (1) PT815855E (id)
SG (1) SG54525A1 (id)
TN (1) TNSN97111A1 (id)
ZA (1) ZA975767B (id)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
EP1163901B1 (en) 1999-02-26 2008-09-10 Shionogi & Co., Ltd. Chewable soft capsules having improved administration properties and process for producing the same
US20030060422A1 (en) 2001-08-31 2003-03-27 Balaji Venkataraman Tannate compositions and methods of treatment
US20050142204A1 (en) * 2001-09-18 2005-06-30 Loetter Antonie P. Triclosan dosage form
US8128957B1 (en) 2002-02-21 2012-03-06 Valeant International (Barbados) Srl Modified release compositions of at least one form of tramadol
US20050182056A9 (en) * 2002-02-21 2005-08-18 Seth Pawan Modified release formulations of at least one form of tramadol
US7670612B2 (en) 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
US20050020613A1 (en) * 2002-09-20 2005-01-27 Alpharma, Inc. Sustained release opioid formulations and method of use
FR2850275B1 (fr) * 2003-01-24 2005-04-08 Scherer Technologies Inc R P Capsules molles a macher contenant une substance active a gout masque
US20040185032A1 (en) * 2003-03-18 2004-09-23 David Burrell Compositions and methods for treating colic
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
US20050249802A1 (en) * 2004-05-06 2005-11-10 The Procter & Gamble Company Softgel encapsulated pharmaceutical compositions comprising concentrated active ingredients
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
EP2488029B1 (en) 2009-09-30 2016-03-23 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse
CN104254323A (zh) * 2012-04-13 2014-12-31 旗帜药物胶囊公司 含有片剂和液体或半固体填充剂的软弹性胶囊及其制备方法
RU2673818C2 (ru) 2012-11-30 2018-11-30 Экьюра Фармасьютикалз, Инк. Саморегулируемое высвобождение фармацевтического ингредиента
HK1218622A1 (zh) * 2013-03-15 2017-03-03 Warner Chilcott Company, Llc 含有改性瓜尔胶的药物软明胶胶囊剂型
CA3042642A1 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2015145459A1 (en) 2014-03-26 2015-10-01 Sun Pharma Advanced Research Company Ltd. Abuse deterrent immediate release coated reservoir solid dosage form
ES2809458T3 (es) 2014-07-17 2021-03-04 Pharmaceutical Manufacturing Res Services Inc Forma de dosificación llena de líquido, disuasoria del abuso y de liberación inmediata
EP3209282A4 (en) 2014-10-20 2018-05-23 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
US11103581B2 (en) 2015-08-31 2021-08-31 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
AU2019225236B2 (en) * 2018-02-26 2025-01-30 R.P. Scherer Technologies, Llc Pharmaceutical dosage form for an emulsion of simethicone and loperamide
KR20210053946A (ko) 2018-08-31 2021-05-12 아틱 테라퓨틱스, 엘엘씨 피내 적용을 위한 신규한 국소 제형 및 그것의 용도

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59131355A (ja) * 1983-01-17 1984-07-28 森下仁丹株式会社 多重軟カプセルの製法
US4486412A (en) * 1983-03-15 1984-12-04 Pharmacaps, Inc. Encapsulated antacid dispersions
EP0211079A4 (en) * 1985-01-31 1988-02-15 Fujisawa Pharmaceutical Co BENDABLE CAPSULE WITH SEVERAL CHAMBERS, METHOD AND DEVICE FOR THEIR PRODUCTION.
JPS61189230A (ja) * 1985-02-19 1986-08-22 Nippon Kayaku Co Ltd エトポシド製剤
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier
US4639846A (en) * 1985-08-16 1987-01-27 Bbc Brown, Boveri & Company, Limited Method and compensating device for compensating current oscillations
US5209978A (en) * 1985-12-26 1993-05-11 Taisho Pharmaceutical Co., Ltd. Seamless soft capsule and production thereof
DE3600084A1 (de) * 1986-01-03 1987-07-09 Scherer Gmbh R P Formkoerper sowie verfahren und vorrichtung zur herstellung eines solchen formkoerpers
US4708834A (en) * 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
DE3727894A1 (de) * 1987-08-21 1989-03-02 Stephan Dieter Kapsel fuer pharmazeutisch wirksame inhaltsstoffe einer droge
FR2624012B1 (fr) * 1987-12-07 1991-05-31 Fdb Ste Civile Rech Nouvelles compositions pharmaceutiques a action hypnotique a base d'hydrate de chloral
US4956184A (en) * 1988-05-06 1990-09-11 Alcide Corporation Topical treatment of genital herpes lesions
US4935243A (en) * 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
US5073384A (en) * 1989-10-19 1991-12-17 Valentine Enterprises, Inc. Maltodextrin/defoaming composition combinate
GB8926612D0 (en) * 1989-11-24 1990-01-17 Erba Farmitalia Pharmaceutical compositions
IE64128B1 (en) * 1990-02-26 1995-07-12 Byrne Rynne Holdings Ltd A pharmaceutical composition
GB9022788D0 (en) * 1990-10-19 1990-12-05 Cortecs Ltd Pharmaceutical formulations
GR1002332B (el) * 1992-05-21 1996-05-16 Mcneil-Ppc Inc. Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη.
US5501857A (en) * 1992-07-24 1996-03-26 Midwestern Bio-Ag Products & Services, Inc. Oral nutritional and dietary composition
ES2161768T3 (es) * 1993-06-30 2001-12-16 Fujisawa Pharmaceutical Co Medicamento encapsulado.
US5725846A (en) * 1995-03-02 1998-03-10 The Gillette Company Clear antiperspirant stick containing dibenzylidene alditol and hydroxyalkyl cellulose

Also Published As

Publication number Publication date
NO972963D0 (no) 1997-06-25
DE69715319D1 (de) 2002-10-17
KR980000438A (ko) 1998-03-30
DK0815855T3 (da) 2003-01-06
CN1172642A (zh) 1998-02-11
MX9704846A (es) 1998-07-31
CZ205697A3 (cs) 1998-01-14
IL121145A0 (en) 1997-11-20
DE69715319T2 (de) 2003-01-23
HU9701113D0 (en) 1997-08-28
EP0815855B1 (en) 2002-09-11
NZ328182A (en) 1998-11-25
ES2183089T3 (es) 2003-03-16
EP0815855A1 (en) 1998-01-07
US6024980A (en) 2000-02-15
ID17794A (id) 1998-01-29
PT815855E (pt) 2003-01-31
BR9703771A (pt) 1998-09-01
TNSN97111A1 (fr) 2005-03-15
ATE223707T1 (de) 2002-09-15
PL320815A1 (en) 1998-01-05
HUP9701113A2 (hu) 1998-08-28
AU2620197A (en) 1998-01-15
ZA975767B (en) 1998-12-28
AR007648A1 (es) 1999-11-10
SG54525A1 (en) 1998-11-16
CO4900025A1 (es) 2000-03-27
JPH10182437A (ja) 1998-07-07

Similar Documents

Publication Publication Date Title
NO972963L (no) Flerfaset mykgelatin-doseringsform
DE69738916D1 (de) Herstellung von pulverförmigem Material
EP0684044A3 (en) A composition containing dendrimer and active ingredient.
MA26568A1 (fr) Association d'un inhibiteur d'aldose-reductase et d'un inhibiteur de glycogene-phosphorylase et composition pharmaceutique la contenant
DZ1916A1 (fr) Composés nouveaux et compostions pharmaceutiques les contenant.
FI964583L (fi) Tokoferolikoostumuksia biologisesti aktiivisten aineiden antamiseksi
DE69811054D1 (de) Verpackung von folienartigen pflaster
DE69634053D1 (de) Oral anzuwendende Arzneizusammensetzung enthaltend 2-Methyl-thienobenzodiazepin
FR2563711B1 (fr) Ensemble pour le conditionnement et l'application d'une substance, notamment cosmetique, se presentant sous la forme solide
DE59811487D1 (de) Mehrphasige wirkstoffhaltige Zubereitungsformen
DZ2494A1 (fr) Composition pharmaceutique d'oméprazole.
MA26502A1 (fr) Analogues peptidiques de la lh-rh, leur utilisation et les compositions pharmaceutiques les contenant.
MX164826B (es) Composicion de cloruro de vinilideno y pelicula hecha a partir de la misma
NO973014D0 (no) Fyllmateriale for farmasöytisk mykgelatin-doseringsform
FR2473884B1 (fr) Associations d'une halogeno-propiophenone et d'une diazepine, medicaments tranquillisants contenant de telles associations, et leur preparation
EP0809509A4 (en) ALLOSTERIC REGULATION OF NUCLEAR HORMONE RECEPTORS
HUP9603302A2 (en) Biaromatic compounds bearing a 4-adamantyl-phenyl group, pharmaceutical and cosmetic compositions containing them and use of the cosmetic compositions
DE69617136D1 (de) Korrektur von taktgeförderten registergenauen Materialbahnen
FR2730995B1 (fr) Composes bi-aromatiques derives d'amide, compositions pharmaceutiques et cosmetiques les contenant et utilisations
BR9810285A (pt) Solução, composição farmacêutica, e, cápsula de gelatina.
ZA968230B (en) Administration of biologically active material
FR2714603B1 (fr) Composition dermatologique et son utilisation pour la préparation d'un médicament.
FR2770109B1 (fr) Applicateur d'une substance, notamment d'une matiere deodorante
ATE206911T1 (de) Feste arzneimittelform mit polymerem material verteiltem wirkstoff
FR2753128B3 (fr) Film d'emballage

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application